Something interesting is happening in urban India. At high-end gyms, members are openly discussing their “Mounjaro progress.” Corporate health plans are fielding requests to cover these medications. Players in the QSR (Quick Service Restaurants) industry are evaluating the impact on their bottom line.  The trigger?  A class of drugs called GLP-1 receptor agonists—medications like Ozempic, … Continue reading The weight-loss revolution that’s changing everything from food ordering to pharma stocks